The Early Detection Research Network (EDRN) is a collaborative program that maintains comprehensive infrastructure and resources critical to the discovery, development and validation of biomarkers for cancer risk and early detection.
The DCP Cancer Biomarkers Research Group administers this program.
On This Page
- All Headings will automatically be pulled in to this list.
- Do not edit the content on this template.
About EDRN
The program comprises a public/private sector consortium to accelerate the development of biomarkers that can improve medical practice, ensure data reproducibility and integrity, and adapt to the changing landscape of biomarker science.
Grantee Details
No matching Grants were found.
News and Events
Prevention and Screening Drive Drop in Cancer Deaths
Date Posted: January 14, 2025
DCP Participation at American Association for Cancer Research (AACR) Annual Meeting, April 5-10, 2024
Date Posted: March 12, 2024
Following Abnormal Cancer Screening Results, Multi-Level Reminders May Increase Follow-Up
Date Posted: December 22, 2023
Identifying New Biomarkers to Detect Lung Cancer Earlier
Date Posted: January 14, 2022